Skip to main content

Table 2 Associated genetic variants in the discovery sample set (n = 96 cases and n = 96 controls)

From: Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease

Chr

Pos (bp)

SNP rs ID

Alt

Ref

F c (%)

F p (%)

OR (95 % CI)

P value

Gene

Coding

RG score

ExAc Eur frequencya

CADD_PHREDb

1

110230569

72989301

G

A

10.0

22.1

2.5 (1.0-6.2)

0.038

GSTM1

 

4

0.24

NA

1

110233057

111436983

C

T

11.6

26.7

2.8 (1.2-6.2)

0.013

GSTM1

 

7

0.24

NA

2

216991935

12694384

A

C

29.4

17.9

0.5 (0.3-0.9)

0.04

XRCC5

 

5

NA

NA

2

218669225

61741262

C

T

13.6

0

NA

0.027

TNS1

p.(Asp1722Ser)

4

0.13

12.49

2

218746990

2303381

T

A

7.7

1.5

0.2 (0.0-0.9)

0.019

TNS1

 

6

NA

NA

3

55520778

566926

T

G

39.2

25.0

0.5 (0.3-0.9)

0.017

WNT5A

 

3a

NA

NA

4

106638697

72671840

G

A

2.3

11.4

5.3 (1.5-18.9)

5.8 × 10−3

GSTCD

 

6

NA

NA

4

106647679

72671858

T

C

3.0

10.5

3.7 (1.2-11.7)

0.026

GSTCD

 

7

NA

NA

4

106755996

11728716

A

G

3.4

21.0

7.4 (2.5-22.5)

6.5 × 10−5

GSTCD

 

1f

NA

NA

5

58284208

3805557

C

T

22.0

11.9

0.5 (0.2-0.9)

0.034

PDE4D

 

7

NA

NA

5

58284283

3805556

G

A

22.0

11.8

0.5 (0.2-0.9)

0.033

PDE4D

 

6

0.84

NA

5

58286625

1553114

C

T

22.0

11.8

0.5 (0.2-0.9)

0.033

PDE4D

 

7

0.84

NA

5

141993867

17223611

T

C

10.6

3.0

0.3 (0.1-0.8)

0.025

FGF1

 

5

NA

NA

6

142703137

2143390

T

C

2.9

19.2

7.9 (1.6-37.6)

4.5 × 10−3

GPR126

p.(Asp373=)

7

0.12

NA

6

151197501

9322290

C

T

17.4

9.0

0.5 (0.2-1.0)

0.047

MTHFD1L

 

5

NA

NA

6

151206894

147872265

T

C

7.6

2.2

0.3 (0.1-1.0)

0.049

MTHFD1L

 

7

0.002

NA

6

151263456

803451

A

G

41.8

55.7

1.8 (1.1-2.9)

0.04

MTHFD1L

 

7

NA

NA

6

151264132

803448

T

C

37.9

50.7

1.7 (1.0-2.7)

0.037

MTHFD1L

 

6

NA

NA

6

152183551

1643821

A

G

25.8

39.0

1.8 (1.1-3.1)

0.026

ESR1

 

6

NA

NA

8

42552530

41272375

C

G

1.5

6.9

4.8 (1.0-22.8)

0.034

CHRNB3

 

5

NA

NA

9

98239503

3780573

A

G

18.3

8.7

0.4 (0.2-0.9)

0.041

PTCH1

 

5

NA

NA

10

81706281

6413520

G

A

0.8

5.9

8.2 (1.0-66.4)

0.036

SFTPD

p.(Ser45=)

5

0.07

NA

10

123358096

41301039

G

C

25.0

2.8

0.1 (0.0-0.7)

0.017

FGFR2

 

4

NA

NA

11

102738499

632009

T

C

29.6

50.8

2.5 (1.5-4.1)

6.7 × 10−4

MMP12

 

7

NA

NA

12

23737566

11046992

A

G

21.2

33.1

1.8 (1.1-3.2)

0.039

SOX5

 

6

NA

NA

12

110224916

60258652

T

C

2.4

10.5

4.7 (1.0-22.9)

0.05

TRPV4

 

5

NA

NA

12

110224922

1861810

A

C

36.6

53.8

2.0 (1.1-3.8)

0.04

TRPV4

 

5

NA

NA

12

110232032

59870578

A

G

7.8

1.6

0.2 (0.0-0.9)

0.034

TRPV4

 

4

NA

NA

12

110232034

59940634

T

G

7.8

1.6

0.2 (0.0-0.9)

0.034

TRPV4

 

4

NA

NA

15

71434029

2004101

A

T

0.8

5.6

7.5 (0.9-61.6)

0.035

THSD4

 

7

NA

NA

15

78790189

2292115

G

A

4.8

0

NA

0.03

IREB2

 

7

NA

NA

15

78911181

8040868

C

T

31.8

47.8

2.0 (1.2-3.2)

8.8 × 10−3

CHRNA3

p.(Val53=)

1f

0.41

NA

16

16130514

903880

A

C

15.9

27.2

2.0 (1.1-3.6)

0.027

ABCC1

 

4

NA

NA

16

16205741

9673292

C

G

4.5

0

NA

0.013

ABCC1

 

6

NA

NA

16

16230290

212087

A

G

38.6

52.2

1.7 (1.1-2.8)

0.028

ABCC1

 

5

0.44

NA

16

16235366

113328089

A

G

6.9

1.5

0.2 (0.0-1.0)

0.034

ABCC1

 

5

NA

NA

20

15967390

41275442

T

C

9.1

17.7

2.1 (1.0-4.5)

0.049

MACROD2

p.(Thr100Met)

4

0.18

3.98

  1. Alt, non-reference allele. Ref, reference allele, OR Odds ratio with 95 % confidence intervals, F c Frequency in controls, F p Frequency in cases (patients), RG Score, RegulomeDB score, NA Not available
  2. aNon-Finnish European allele frequency extracted from ExAc v.0.3.1
  3. bThe “PHRED-scaled” CADD score based on ranks of all SNV in the hg19 genome reference